These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 12192020)

  • 21. [TTP/HUS].
    Suzuki M; Ikeda Y
    Nihon Rinsho; 2004 May; 62 Suppl 5():482-5. PubMed ID: 15197968
    [No Abstract]   [Full Text] [Related]  

  • 22. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
    Furlan M
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Progress on TTP/HUS diagnosis with analysis of VWF-cleaving protease activation].
    Fujimura Y
    Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):451-9. PubMed ID: 15052802
    [No Abstract]   [Full Text] [Related]  

  • 24. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The "cutting" edge: von Willebrand factor-cleaving protease activity in thrombotic microangiopathies.
    Haspel RL; Jarolím P
    Transfus Apher Sci; 2005 Apr; 32(2):177-84. PubMed ID: 15784452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies.
    Moake J
    Best Pract Res Clin Haematol; 2009 Dec; 22(4):567-76. PubMed ID: 19959109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Processing of von Willebrand factor by ADAMTS-13.
    Chung DW; Fujikawa K
    Biochemistry; 2002 Sep; 41(37):11065-70. PubMed ID: 12220170
    [No Abstract]   [Full Text] [Related]  

  • 28. [Thrombotic microangiopathy: thrombocytopenia and hemolytic anemia].
    Kater AP; van der Lelie J; Levi M
    Ned Tijdschr Geneeskd; 2002 Dec; 146(49):2343-7. PubMed ID: 12510396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Sarkodee-Adoo C; Gojo I; Heyman MR
    N Engl J Med; 1999 Apr; 340(17):1368; author reply 1369. PubMed ID: 10223876
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].
    Masset C; Dubois B; Rorive G
    Rev Med Liege; 2002 Jan; 57(1):33-9. PubMed ID: 11899496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moschcowitz, multimers, and metalloprotease.
    Moake JL
    N Engl J Med; 1998 Nov; 339(22):1629-31. PubMed ID: 9828253
    [No Abstract]   [Full Text] [Related]  

  • 32. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
    Tsai HM
    J Mol Med (Berl); 2002 Oct; 80(10):639-47. PubMed ID: 12395148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity.
    Mori Y; Wada H; Gabazza EC; Minami N; Nobori T; Shiku H; Yagi H; Ishizashi H; Matsumoto M; Fujimura Y
    Transfusion; 2002 May; 42(5):572-80. PubMed ID: 12084165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury.
    Nguyen TC; Cruz MA; Carcillo JA
    Crit Care Clin; 2015 Oct; 31(4):661-74. PubMed ID: 26410136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemolytic uremic syndrome (HUS). An up-dated nosological classification].
    Repetto HA
    Medicina (B Aires); 2006; 66 Suppl 3():2-5. PubMed ID: 17354469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. von Willebrand factor in thrombotic thrombocytopenic purpura.
    Furlan M; Lämmle B
    Thromb Haemost; 1999 Aug; 82(2):592-600. PubMed ID: 10605756
    [No Abstract]   [Full Text] [Related]  

  • 37. Thrombotic microangiopathies: from empiricism to targeted therapies.
    Coppo P
    Presse Med; 2012 Mar; 41(3 Pt 2):e101-4. PubMed ID: 22317842
    [No Abstract]   [Full Text] [Related]  

  • 38. Familial and recurrent forms of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura.
    Noris M; Remuzzi G
    Contrib Nephrol; 2001; (136):125-39. PubMed ID: 11688376
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of von Willebrand factor (vWF) in thrombotic thrombocytopenic purpura (TTP) and the hemolytic-uremic syndrome (HUS).
    Moake JL
    Prog Clin Biol Res; 1990; 337():135-40. PubMed ID: 2191307
    [No Abstract]   [Full Text] [Related]  

  • 40. The molecular biology of thrombotic microangiopathy.
    Tsai HM
    Kidney Int; 2006 Jul; 70(1):16-23. PubMed ID: 16760911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.